(E/Z)-Mirin
Based on 10 publication(s) in Google Scholar
(E/Z)-Mirin is a mixture of (E)-Mirin and Mirin ((Z)-Mirin) (HY-19959) configurations. Among them, Mirin is an inhibitor of MRN (Mre11-Rad50-Nbs1). Mirin prevents MRN-dependent ATM activation without affecting ATM protein kinase activity.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.22%
- CAS No.: 299953-00-7
- 화학식: C10H8N2O2S
- 분자량:220.25
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) (E/Z)-Mirin
More- Cell Stem Cell. 2026 Mar 5;33(3):470-486.e14. [Abstract]
- Nat Cell Biol. 2025 Jun;27(6):992-1005. [Abstract]
- Nat Chem Biol. 2025 Aug;21(8):1182-1193. [Abstract]
- Nucleic Acids Res. 2025 Mar 20;53(6):gkaf200. [Abstract]
- Adv Sci (Weinh). 2024 Aug;11(30):e2307751. [Abstract]
- Mol Cancer Ther. 2026 Jul 15:10.1158/1535-7163.MCT-26-0182.
- PLoS Pathog. 2025 Jan 3;21(1):e1012824. [Abstract]
- bioRxiv. 2025 Aug 21.
- bioRxiv. 2025 Apr 18:2025.04.15.648906. [Abstract]
- bioRxiv. 2023: 2023.11
-
Bio/Physico-chemical Assay
-
Bio/Physico-chemical Assay
-
Bio/Physico-chemical Assay
-
ELISA
-
Bio/Physico-chemical Assay
Biological Activity
제품 설명
In Vitro
Mirin inhibits H2AX phosphorylation with an IC50 of 66 μM. Mirin also inhibits ATM-dependent phosphorylation of downstream targets Nbs1 and Chk2, as well as MRN-dependent autophosphorylation of ATM at Ser1981 in DSB reactions. Mirin at concentrations of 50 μM and 100 μM induces significant G2 arrest. Mirin (10-100 μM) inhibits homology-dependent DNA repair in TOSA4 cells[1].
BRCA2-deficient cells also show hypersensitivity to the Mre11 inhibitor Mirin[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 299953-00-7
-
Appearance Solid
-
분자량 220.25
-
화학식 C10H8N2O2S
-
Color Yellow to orange
-
SMILES
O=C1N=C(N)S/C1=C/C2=CC=C(O)C=C2
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (10)
-
Journal Impact Factor
-
Most Recent
-
Cell Stem Cell
Minimizing far-extending chromatin perturbation in genome editing preserves stem cell identity. [Abstract]2026 Mar 5;33(3):470-486.e14. PMID: 41742419
(E/Z)-Mirin purchased from MedChemExpress. Usage Cited in: Cell Stem Cell. 2026 Mar 5;33(3):470-486.e14. [Abstract]
ΔATAC profile of editing loci Emx1 (left) and Tyr (right) under different concentrations of (E/Z)-Mirin (25-200 μM) in NIH3T3 cells.
(E/Z)-Mirin purchased from MedChemExpress. Usage Cited in: Cell Stem Cell. 2026 Mar 5;33(3):470-486.e14. [Abstract]
(E/Z)-Mirin (50 μM; 2 d) reduced the genome-editing-induced stem cell loss without compromising editing efficiency.
-
Nat Cell Biol
Transcriptional repression facilitates RNA:DNA hybrid accumulation at DNA double-strand breaks. [Abstract]2025 Jun;27(6):992-1005. PMID: 40447771
(E/Z)-Mirin purchased from MedChemExpress. Usage Cited in: Nat Cell Biol. 2025 Jun;27(6):992-1005. [Abstract]
(E/Z)-Mirin (100 μM; 1 h) decreased RNA:DNA hybrids at DSBs.
-
Nat Chem Biol
2025 Aug;21(8):1182-1193. PMID: 39809895 -
Nucleic Acids Res
Homeodomain protein PRRX1 anchors the Ku heterodimers at DNA double-strand breaks to promote nonhomologous end-joining. [Abstract]2025 Mar 20;53(6):gkaf200. PMID: 40114375 -
Adv Sci (Weinh)
The Compromised Fanconi Anemia Pathway in Prelamin A-Expressing Cells Contributes to Replication Stress-Induced Genomic Instability. [Abstract]2024 Aug;11(30):e2307751. PMID: 38894550
(E/Z)-Mirin purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Aug;11(30):e2307751. [Abstract]
MRE11 inhibitor (E/Z)-Mirin (50 µM; 4 h) alleviated HU-induced genomic instability in prelamin A-expressing cells.
-
-
PLoS Pathog
2025 Jan 3;21(1):e1012824. PMID: 39752632
(E/Z)-Mirin purchased from MedChemExpress. Usage Cited in: PLoS Pathog. 2025 Jan 3;21(1):e1012824. [Abstract]
(E/Z)-Mirin (25-50 μM; 5 d) decreased the levels of HBeAg in HepG2-NTCP-K7 cells in a dose-dependent manner.
-
-
bioRxiv
2025 Apr 18:2025.04.15.648906. PMID: 40321211 -
용액&용해도
In Vitro:
DMSO : 83.33 mg/mL (378.34 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
순도&문서
-
Data Sheet (272 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Dupré A, et al. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol. 2008;4(2):119-125. [Content Brief]
[2]. Ying S, et al. Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1. Cancer Res. 2012;72(11):2814-2821. [Content Brief]
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.5403 mL | 22.7015 mL | 45.4030 mL | 113.5074 mL |
| 5 mM | 0.9081 mL | 4.5403 mL | 9.0806 mL | 22.7015 mL | |
| 10 mM | 0.4540 mL | 2.2701 mL | 4.5403 mL | 11.3507 mL | |
| 15 mM | 0.3027 mL | 1.5134 mL | 3.0269 mL | 7.5672 mL | |
| 20 mM | 0.2270 mL | 1.1351 mL | 2.2701 mL | 5.6754 mL | |
| 25 mM | 0.1816 mL | 0.9081 mL | 1.8161 mL | 4.5403 mL | |
| 30 mM | 0.1513 mL | 0.7567 mL | 1.5134 mL | 3.7836 mL | |
| 40 mM | 0.1135 mL | 0.5675 mL | 1.1351 mL | 2.8377 mL | |
| 50 mM | 0.0908 mL | 0.4540 mL | 0.9081 mL | 2.2701 mL | |
| 60 mM | 0.0757 mL | 0.3784 mL | 0.7567 mL | 1.8918 mL | |
| 80 mM | 0.0568 mL | 0.2838 mL | 0.5675 mL | 1.4188 mL | |
| 100 mM | 0.0454 mL | 0.2270 mL | 0.4540 mL | 1.1351 mL |